Dr.Ahmed Abdulgawad – Best Costs, Reviews – Book Your Consultation

Professional Experience

• Haematology Consultant, Cellular Therapy Lead, The Christie NHS Foundation Trust (from 1 February 2023)
• Senior Early Phase Trials Fellow, The Christie (March 2022 – February 2023)
• Haematology Specialty Trainee, Northwest region of Health Education England (2019 – 2023)
• Senior Clinical Fellow in Bone Marrow Transplant, King’s College Hospital, London (2017 – 2019)
• Earlier role as Lecturer in Internal Medicine and Haematology, Cairo University, Egypt (from 2014)

Academic Contributions

• Active researcher in haematology, with publications on CAR-T therapy, stem cell transplantation, thrombosis in myeloproliferative diseases
• Contributor of book chapters, e.g. on amyloidosis and venous thromboembolism prophylaxis in surgical settings
• Frequent participant and co-investigator in early-phase clinical trials and cellular therapy studies
• Listed on ResearchGate with publications and collaborations in advanced haematology research

Areas of Expertise

• Cellular therapy (e.g. CAR-T and adoptive cell therapies)
• Early-phase clinical trials for haematological malignancies
• Bone marrow transplantation and engraftment kinetics research
• Immunotherapy approaches (BiTEs, ADCs, TCE)
• Coagulation disorders, thrombosis in myeloproliferative diseases

Publications and Research

Patient Care Philosophy

• Clear, empathetic communication: explaining complex cellular therapies and trial processes in understandable terms
• Shared decision-making: involving patients fully in therapeutic choices and risks
• Focus on safety and rigorous ethical standards in experimental treatments
• Respect for diversity and cultural sensitivity, including care for international or non-English speaking patients
• Commitment to advancing treatment options through clinical research, giving patients access to novel therapies

Professional Affiliations

• Member of General Medical Council (GMC), UK — haematology specialist register (entered 2023)
• Fellow of the Royal College of Pathologists (FRCPath)
• MRCP (Membership of the Royal Colleges of Physicians)
• Contributor or collaborator on national/international haematology and cellular therapy trials and networks

FAQs

Is Ahmed Abdulgawad board-certified?

Yes — he is registered on the UK haematology specialist register (from 2023), and holds MRCP and FRCPath.

What types of treatments does he provide?

He leads and delivers cellular therapies (such as CAR-T), early-phase experimental treatments, transplant support, and immunotherapy in haematological malignancies.

Does he treat international patients?

Yes — as part of The Christie, which has a national and international reputation, referrals from abroad are accepted.

How long is the typical hospital stay?

Depends heavily on treatment type — some cellular therapy procedures or transplants require longer inpatient stays, while early-phase or monitoring visits may be outpatient.

What languages does he speak?

He speaks English and Arabic (native or bilingual).

Is he still active in research?

Yes — he continues to publish, mentor and lead roles in clinical trials and cellular therapy development.